[Retracted] Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma

Yi Shi, Xiaofei Mo, Simei Hong, Tianbao Li, Baozhen Chen, Gang Chen

Open source

DOI
10.1155/2020/4965670
Published
2020-01
Container
BioMed Research International
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2020/4965670,
  title = {[Retracted] Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma},
  author = {Yi Shi and Xiaofei Mo and Simei Hong and Tianbao Li and Baozhen Chen and Gang Chen},
  year = {2020},
  journal = {BioMed Research International},
  doi = {10.1155/2020/4965670},
  url = {https://doi.org/10.1155/2020/4965670}
}

RIS

TY  - JOUR
TI  - [Retracted] Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma
AU  - Yi Shi
AU  - Xiaofei Mo
AU  - Simei Hong
AU  - Tianbao Li
AU  - Baozhen Chen
AU  - Gang Chen
PY  - 2020
JO  - BioMed Research International
DO  - 10.1155/2020/4965670
UR  - https://doi.org/10.1155/2020/4965670
ER  - 

APA

Shi, Y., Mo, X., Hong, S., Li, T., Chen, B., & Chen, G. (2020). [Retracted] Studying the Role and Molecular Mechanisms of MAP4K3 in Sorafenib Resistance of Hepatocellular Carcinoma. BioMed Research International. https://doi.org/10.1155/2020/4965670

Source records